Serum copeptin levels in adolescents with primary hypertension.
about
Pathophysiology of copeptin in kidney disease and hypertensionMetabolic and Kidney Diseases in the Setting of Climate Change, Water Shortage, and Survival FactorsRole of enteroendocrine L-cells in arginine vasopressin-mediated inhibition of colonic anion secretion.Biomarkers in hypertension and their relationship with myocardial target-organ damage.Use of Biomarkers in the Evaluation and Treatment of Hypertensive Patients.Copeptin in obese children and adolescents: relationships to body mass index, cortisol and gender.Copeptin, resistant hypertension and renal sympathetic denervation.
P2860
Q33792317-D777A461-8AE6-47D0-B0F4-45737FB13634Q36047669-21558FC0-F7D0-4216-8DF6-8FBA0CED7CE9Q37228951-882EBAF5-75BD-4635-826E-6599059C5BB5Q38258970-942F1C12-FF78-4C31-A195-F91715557FF8Q38843567-348E6A7D-9178-412C-BB23-CAD9188F149CQ39394021-E0611E15-A161-4487-A6A4-BE4D1D2B4C19Q51753457-0D29814E-3048-4926-AE1E-21A55FAB11FA
P2860
Serum copeptin levels in adolescents with primary hypertension.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 29 December 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Serum copeptin levels in adolescents with primary hypertension.
@en
Serum copeptin levels in adolescents with primary hypertension.
@nl
type
label
Serum copeptin levels in adolescents with primary hypertension.
@en
Serum copeptin levels in adolescents with primary hypertension.
@nl
prefLabel
Serum copeptin levels in adolescents with primary hypertension.
@en
Serum copeptin levels in adolescents with primary hypertension.
@nl
P2093
P2860
P1433
P1476
Serum copeptin levels in adolescents with primary hypertension.
@en
P2093
Anna Wasilewska
Marlena Waszkiewicz-Stojda
Renata Filonowicz
Urszula Jakubowska
P2860
P2888
P304
P356
10.1007/S00467-013-2683-5
P577
2013-12-29T00:00:00Z